The 3-hydroxyacyl-CoA dehydratases HACD1 and HACD2 exhibit functional redundancy and are active in a wide range of fatty acid elongation pathways

J Biol Chem. 2017 Sep 15;292(37):15538-15551. doi: 10.1074/jbc.M117.803171. Epub 2017 Aug 7.

Abstract

Differences among fatty acids (FAs) in chain length and number of double bonds create lipid diversity. FA elongation proceeds via a four-step reaction cycle, in which the 3-hydroxyacyl-CoA dehydratases (HACDs) HACD1-4 catalyze the third step. However, the contribution of each HACD to 3-hydroxyacyl-CoA dehydratase activity in certain tissues or in different FA elongation pathways remains unclear. HACD1 is specifically expressed in muscles and is a myopathy-causative gene. Here, we generated Hacd1 KO mice and observed that these mice had reduced body and skeletal muscle weights. In skeletal muscle, HACD1 mRNA expression was by far the highest among the HACDs However, we observed only an ∼40% reduction in HACD activity and no changes in membrane lipid composition in Hacd1-KO skeletal muscle, suggesting that some HACD activities are redundant. Moreover, when expressed in yeast, both HACD1 and HACD2 participated in saturated and monounsaturated FA elongation pathways. Disruption of HACD2 in the haploid human cell line HAP1 significantly reduced FA elongation activities toward both saturated and unsaturated FAs, and HACD1 HACD2 double disruption resulted in a further reduction. Overexpressed HACD3 exhibited weak activity in saturated and monounsaturated FA elongation pathways, and no activity was detected for HACD4. We therefore conclude that HACD1 and HACD2 exhibit redundant activities in a wide range of FA elongation pathways, including those for saturated to polyunsaturated FAs, with HACD2 being the major 3-hydroxyacyl-CoA dehydratase. Our findings are important for furthering the understanding of the molecular mechanisms in FA elongation and diversity.

Keywords: 3-hydroxyacyl-CoA dehydratase; endoplasmic reticulum (ER); fatty acid; fatty acid elongation; fatty acid metabolism; lipid; muscle; myopathy; very long-chain fatty acid.

MeSH terms

  • Animals
  • CRISPR-Cas Systems
  • Catalytic Domain
  • Cell Line, Tumor
  • Cells, Cultured
  • Fatty Acids / chemistry
  • Fatty Acids / metabolism*
  • Gene Expression Regulation, Enzymologic
  • Humans
  • Hydro-Lyases / genetics
  • Hydro-Lyases / metabolism*
  • Isoenzymes / genetics
  • Isoenzymes / metabolism
  • Male
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism*
  • Mice, Knockout
  • Molecular Structure
  • Molecular Weight
  • Muscle, Skeletal / cytology
  • Muscle, Skeletal / enzymology*
  • Muscle, Skeletal / pathology
  • Muscular Diseases / enzymology
  • Muscular Diseases / genetics
  • Muscular Diseases / pathology
  • Myoblasts, Skeletal / cytology
  • Myoblasts, Skeletal / enzymology*
  • Myoblasts, Skeletal / pathology
  • Protein Tyrosine Phosphatases / genetics
  • Protein Tyrosine Phosphatases / metabolism*
  • Recombinant Fusion Proteins / metabolism
  • Substrate Specificity

Substances

  • Fatty Acids
  • Isoenzymes
  • Membrane Proteins
  • Recombinant Fusion Proteins
  • HACD1 protein, human
  • Hacd1 protein, mouse
  • Protein Tyrosine Phosphatases
  • D-3-hydroxyacyl CoA dehydratase
  • Hydro-Lyases
  • HACD2 protein, human